Interpace Diagnostics has promoted Greg Richard to the position of chief commercial officer. He previously served as senior vice president of commercial operations. Richard has worked in the healthcare business in various positions for more than 25 years, starting in sales at Aetna, and then moving to Genentech as the director of managed care. He also served as vice president of managed care for Quest Diagnostics, vice president of sales for the Northeast division of LabCorp, and worked for several privately held companies focused in various areas including specialty CROs, molecular diagnostics, and anatomic pathology services.
SQI Diagnostics announced Eric Brouwer has joined the firm as chief scientific officer. He will be responsible for executing SQI's R&D program. Brouwer was most recently CSO of Trinity Biotech and CEO of Trinity's Swedish subsidiary Fiomi Diagnostics. Before that he spent 15 years at Abbott Laboratories.
Sema4, a sequencing and informatics spinout from New York's Mount Sinai Health System, has hired Jamie Coffin as president and chief operating officer. Coffin has more than 20 years of leadership experience in health IT, most recently as CEO of ambulatory surgical EHR vendor Source Medical Solutions. He also was general manager of Dell's former Healthcare and Life Sciences group.
For more recent items on executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.